\-\ Texto\\:\\ \ \(0\)\
\-\ right\\ eye\\ was\\ dilated\\ and\\ deviated\\ laterally\\ and\\ downward\\.\\ \\ there\\ was\\ mild\\ ptosis\\ of\\ the\\ right\\ eyelid\\ with\\ watering\\ and\\ tearing\\ of\\ the\\ right\\ eye\\.\\ \\ no\\ conjunctival\\ injection\\.\\ \\ no\\ hemorrhage\\ noted\\ on\\ fundoscopic\\ exam\\.\\ \\ no\\ other\\ physical\\ abnormalities\\ or\\ focal\\ neurological\\ deficits\\.\\ \\ no\\ cutaneous\\ manifestations\\ of\\ underlying\\ disease\\.\ \(0\)\
\-\ radiation\\ therapy\ \(165\)\
\-\ 1\\)\\ axial\\ t1\\ flair\\,\\ post\\ contrast\\,\\ demonstrates\\ a\\ fusiform\\ enhancing\\ mass\\ extending\\ into\\ the\\ dorsal\\ midbrain\\ and\\ interpenduncular\\ cistern\\ measuring\\ 10\\ x\\ 16\\ x\\ 6\\ mm\ \(0\)\
\-\ 2\\)\\ sagittal\\ t1\\ flair\\,\\ post\\ contrast\\,\\ demonstrating\\ a\\ mass\\ measuring\\ 10\\ x\\ 16\\ x\\ 6\\ mm\\ near\\ the\\ right\\ third\\ cranial\\ nerve\ \(0\)\
\-\ 3\\)\\ two\\ month\\ follow\\ up\\,\\ axial\\ t1\\ ideal\\ 3\\ mm\\,\\ tumor\\ now\\ measuring\\ 27\\ x\\ 22\\ x\\ 20\ \(0\)\
\-\ 4\\)\\ two\\ month\\ follow\\ up\\,\\ sagittal\\ t1\\ flair\\ with\\ contrast\\,\\ tumor\\ now\\ measuring\\ 27\\ x\\ 22\\ x\\ 20\ \(0\)\
\-\ atypical\\ teratoid\\/rhabdoid\\ tumor\ \(1\)\
\-\ 1\\.\\ atypical\\ teratoid\\/rhabdoid\\ tumor\ \(0\)\
\-\ 2\\.\\ primitive\\ neurectodermal\\ tumor\ \(0\)\
\-\ 3\\.\\ ependymoma\ \(0\)\
\-\ 4\\.\\ teratoma\ \(0\)\
\-\ 5\\.\\ choroid\\ plexus\\ tumor\ \(0\)\
\-\ 6\\.\\ pilocytic\\ astrocytoma\ \(0\)\
\-\ 7\\.\\ desmoplastic\\ infantile\\ ganglioglioma\ \(0\)\
\-\ 8\\.\\ schwannoma\ \(0\)\
\-\ patient\\ is\\ a\\ 21\\-month\\-old\\ female\\,\\ with\\ no\\ significant\\ medical\\ history\\,\\ referred\\ by\\ her\\ primary\\ care\\ physician\\ for\\ worsening\\ right\\ eye\\ redness\\ and\\ droopy\\ eyelid\\.\\ \\ two\\ weeks\\ prior\\ to\\ presentation\\,\\ the\\ patient\\â\\€\\™s\\ mother\\ brought\\ her\\ to\\ the\\ primary\\ care\\ physician\\,\\ after\\ she\\ had\\ noticed\\ tearing\\ of\\ the\\ right\\ eye\\ and\\ drooping\\ of\\ the\\ right\\ eyelid\\.\\ \\ she\\ was\\ treated\\ for\\ conjunctivitis\\,\\ but\\ then\\ returned\\ ten\\ days\\ later\\ due\\ to\\ worsening\\ of\\ the\\ redness\\ and\\ tearing\\.\\ \\ the\\ patient\\ was\\ then\\ referred\\ to\\ the\\ ophthalmologist\\,\\ who\\ noted\\ a\\ right\\ cn\\ iii\\ palsy\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ x\\:\\ 0\\.08054475243849935\ \(0\)\
\-\ eyelid\\:\\ 0\\.0654371595306888\ \(0\)\
\-\ tearing\\:\\ 0\\.0640961258561816\ \(0\)\
\-\ eye\\:\\ 0\\.05120585438731302\ \(0\)\
\-\ teratoid\\/rhabdoid\\:\\ 0\\.04906863053507989\ \(0\)\
\-\ measuring\\:\\ 0\\.048819367463553504\ \(0\)\
\-\ tumor\\:\\ 0\\.04269069217737453\ \(0\)\
\-\ flair\\:\\ 0\\.04197512811445272\ \(0\)\
\-\ redness\\:\\ 0\\.04057160148598106\ \(0\)\
\-\ t1\\:\\ 0\\.03869279337463205\ \(0\)\
\-\ mm\\:\\ 0\\.033666376679946486\ \(0\)\
\-\ neurectodermal\\:\\ 0\\.03148399437130892\ \(0\)\
\-\ 21\\-month\\-old\\:\\ 0\\.03148399437130892\ \(0\)\
\-\ watering\\:\\ 0\\.029008468726451974\ \(0\)\
\-\ interpenduncular\\:\\ 0\\.029008468726451974\ \(0\)\
\-\ droopy\\:\\ 0\\.029008468726451974\ \(0\)\
\-\ physician\\:\\ 0\\.028771619151317516\ \(0\)\
\-\ 27\\:\\ 0\\.02831062971462058\ \(0\)\
\-\ 16\\:\\ 0\\.027619703811345212\ \(0\)\
\-\ 22\\:\\ 0\\.027225515128721706\ \(0\)\
\-\ ideal\\:\\ 0\\.026532943081595026\ \(0\)\
\-\ atypical\\:\\ 0\\.02645379025435682\ \(0\)\
\-\ two\\:\\ 0\\.02622140611731435\ \(0\)\
\-\ right\\:\\ 0\\.02576090597458333\ \(0\)\
\-\ drooping\\:\\ 0\\.024534315267539946\ \(0\)\
\-\ conjunctivitis\\:\\ 0\\.024534315267539946\ \(0\)\
\-\ sagittal\\:\\ 0\\.024345333232188425\ \(0\)\
\-\ worsening\\:\\ 0\\.024031999788577126\ \(0\)\
\-\ conjunctival\\:\\ 0\\.023260476182044472\ \(0\)\
\-\ referred\\:\\ 0\\.02303236745325458\ \(0\)\
\-\ desmoplastic\\:\\ 0\\.022609327764923203\ \(0\)\
\-\ ophthalmologist\\:\\ 0\\.022609327764923203\ \(0\)\
\-\ fundoscopic\\:\\ 0\\.02232346095180343\ \(0\)\
\-\ care\\:\\ 0\\.022015551050491088\ \(0\)\
\-\ 20\\:\\ 0\\.02194653740112154\ \(0\)\
\-\ deviated\\:\\ 0\\.021812386510229598\ \(0\)\
\-\ then\\:\\ 0\\.02172119198872921\ \(0\)\
\-\ ptosis\\:\\ 0\\.021161238093108336\ \(0\)\
\-\ ten\\:\\ 0\\.021161238093108336\ \(0\)\
\-\ now\\:\\ 0\\.020865111355011765\ \(0\)\
\-\ 10\\:\\ 0\\.020575887345335074\ \(0\)\
\-\ contrast\\:\\ 0\\.020494025215798985\ \(0\)\
\-\ downward\\:\\ 0\\.019847935306946483\ \(0\)\
\-\ primitive\\:\\ 0\\.019847935306946483\ \(0\)\
\-\ infantile\\:\\ 0\\.019847935306946483\ \(0\)\
\-\ follow\\:\\ 0\\.01939428194247453\ \(0\)\
\-\ post\\:\\ 0\\.019220250236230668\ \(0\)\
\-\ midbrain\\:\\ 0\\.019219754355290542\ \(0\)\
\-\ fusiform\\:\\ 0\\.018492615229428973\ \(0\)\
\-\ her\\:\\ 0\\.018352940417749538\ \(0\)\
\-\ month\\:\\ 0\\.018311532434290068\ \(0\)\
\-\ 6\\:\\ 0\\.018229429724106246\ \(0\)\
\-\ primary\\:\\ 0\\.018081316163540688\ \(0\)\
\-\ ganglioglioma\\:\\ 0\\.017969031393029418\ \(0\)\
\-\ cutaneous\\:\\ 0\\.017733467222344427\ \(0\)\
\-\ axial\\:\\ 0\\.01741993911477051\ \(0\)\
\-\ manifestations\\:\\ 0\\.017372409662089538\ \(0\)\
\-\ she\\:\\ 0\\.017134186724672658\ \(0\)\
\-\ laterally\\:\\ 0\\.0171077383329691\ \(0\)\
\-\ 8\\.\\:\\ 0\\.0170445255576141\ \(0\)\
\-\ palsy\\:\\ 0\\.01692136064307421\ \(0\)\
\-\ noticed\\:\\ 0\\.016687084634196304\ \(0\)\
\-\ brought\\:\\ 0\\.01657546840739593\ \(0\)\
\-\ cn\\:\\ 0\\.016414323995679967\ \(0\)\
\-\ up\\:\\ 0\\.016413193936101595\ \(0\)\
\-\ cistern\\:\\ 0\\.016310797078275496\ \(0\)\
\-\ 7\\.\\:\\ 0\\.01626013766758994\ \(0\)\
\-\ pilocytic\\:\\ 0\\.0160643939658221\ \(0\)\
\-\ returned\\:\\ 0\\.015617382740986363\ \(0\)\
\-\ choroid\\:\\ 0\\.015575611170403536\ \(0\)\
\-\ dorsal\\:\\ 0\\.015534322518971123\ \(0\)\
\-\ no\\:\\ 0\\.01536507411971075\ \(0\)\
\-\ plexus\\:\\ 0\\.014828854749480112\ \(0\)\
\-\ 6\\.\\:\\ 0\\.014828854749480112\ \(0\)\
\-\ noted\\:\\ 0\\.014467294203232811\ \(0\)\
\-\ iii\\:\\ 0\\.014326776354404434\ \(0\)\
\-\ 3\\:\\ 0\\.01429268233361814\ \(0\)\
\-\ teratoma\\:\\ 0\\.014268703065576647\ \(0\)\
\-\ injection\\:\\ 0\\.014240016738086418\ \(0\)\
\-\ was\\:\\ 0\\.014118250317338382\ \(0\)\
\-\ deficits\\:\\ 0\\.01396515587688596\ \(0\)\
\-\ schwannoma\\:\\ 0\\.013938798350823022\ \(0\)\
\-\ mother\\:\\ 0\\.013938798350823022\ \(0\)\
\-\ ependymoma\\:\\ 0\\.013661020847099149\ \(0\)\
\-\ \\,\\:\\ 0\\.01353550327586437\ \(0\)\
\-\ cranial\\:\\ 0\\.013270185700508213\ \(0\)\
\-\ demonstrating\\:\\ 0\\.013248474821663992\ \(0\)\
\-\ neurological\\:\\ 0\\.013205445041249084\ \(0\)\
\-\ near\\:\\ 0\\.013205445041249084\ \(0\)\
\-\ 5\\.\\:\\ 0\\.013162927532297945\ \(0\)\
\-\ underlying\\:\\ 0\\.013079381533816853\ \(0\)\
\-\ third\\:\\ 0\\.012237309621964275\ \(0\)\
\-\ 4\\.\\:\\ 0\\.012015999894288563\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.011851250709547486\ \(0\)\
\-\ abnormalities\\:\\ 0\\.011209873648922201\ \(0\)\
\-\ dilated\\:\\ 0\\.011089612166398673\ \(0\)\
\-\ later\\:\\ 0\\.011019352289260442\ \(0\)\
\-\ nerve\\:\\ 0\\.010996236166026093\ \(0\)\
\-\ presentation\\:\\ 0\\.010512145123182437\ \(0\)\
\-\ 3\\.\\:\\ 0\\.010442407900502597\ \(0\)\
\-\ extending\\:\\ 0\\.010259710888713561\ \(0\)\
\-\ \\)\\:\\ 0\\.010193395601618643\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.010158059229200126\ \(0\)\
\-\ radiation\\:\\ 0\\.010015183034151201\ \(0\)\
\-\ 2\\.\\:\\ 0\\.009705157649286636\ \(0\)\
\-\ enhancing\\:\\ 0\\.00957126261744557\ \(0\)\
\-\ 1\\.\\:\\ 0\\.00953281845106286\ \(0\)\
\-\ medical\\:\\ 0\\.009390392143092872\ \(0\)\
\-\ days\\:\\ 0\\.009353836772042776\ \(0\)\
\-\ patient\\:\\ 0\\.009177770688389871\ \(0\)\
\-\ treated\\:\\ 0\\.009135181557442354\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.009121524070162342\ \(0\)\
\-\ s\\:\\ 0\\.008752741668266383\ \(0\)\
\-\ focal\\:\\ 0\\.008716048586208579\ \(0\)\
\-\ weeks\\:\\ 0\\.008661706274646958\ \(0\)\
\-\ 4\\:\\ 0\\.008503471089925161\ \(0\)\
\-\ mass\\:\\ 0\\.008489007192482603\ \(0\)\
\-\ significant\\:\\ 0\\.008206596968050798\ \(0\)\
\-\ therapy\\:\\ 0\\.008159431415145047\ \(0\)\
\-\ due\\:\\ 0\\.00814384697483157\ \(0\)\
\-\ mild\\:\\ 0\\.008036619478325489\ \(0\)\
\-\ who\\:\\ 0\\.007957030032648936\ \(0\)\
\-\ prior\\:\\ 0\\.007836117043579869\ \(0\)\
\-\ physical\\:\\ 0\\.007487518819932993\ \(0\)\
\-\ 1\\:\\ 0\\.0072618798855703815\ \(0\)\
\-\ into\\:\\ 0\\.0072618798855703815\ \(0\)\
\-\ other\\:\\ 0\\.007034423388223031\ \(0\)\
\-\ exam\\:\\ 0\\.006704406928391207\ \(0\)\
\-\ demonstrates\\:\\ 0\\.006666504291618521\ \(0\)\
\-\ had\\:\\ 0\\.006585177925859672\ \(0\)\
\-\ 2\\:\\ 0\\.006571801773251951\ \(0\)\
\-\ but\\:\\ 0\\.006508940360834063\ \(0\)\
\-\ after\\:\\ 0\\.00631429000931858\ \(0\)\
\-\ female\\:\\ 0\\.0062741438265994055\ \(0\)\
\-\ to\\:\\ 0\\.006100972977756946\ \(0\)\
\-\ a\\:\\ 0\\.005665711454551446\ \(0\)\
\-\ the\\:\\ 0\\.005431221899071013\ \(0\)\
\-\ for\\:\\ 0\\.005207915347447965\ \(0\)\
\-\ by\\:\\ 0\\.005081681797303124\ \(0\)\
\-\ disease\\:\\ 0\\.004988348361484657\ \(0\)\
\-\ there\\:\\ 0\\.004541841273089245\ \(0\)\
\-\ and\\:\\ 0\\.004500225143305461\ \(0\)\
\-\ history\\:\\ 0\\.0042150519203824404\ \(0\)\
\-\ or\\:\\ 0\\.0035768669605846697\ \(0\)\
\-\ on\\:\\ 0\\.002585325044162243\ \(0\)\
\-\ of\\:\\ 0\\.002496510017099752\ \(0\)\
\-\ is\\:\\ 0\\.00200818135137402\ \(0\)\
\-\ \\.\\:\\ 0\\.001267840574905224\ \(0\)\
\-\ with\\:\\ 0\\.0012536161723916757\ \(0\)\
